key: cord-0941395-v8sv890w authors: Bevilacqua, Michele; De Togni, Paolo; Cattazzo, Filippo; Dell'Atti, Davide; Dalbeni, Andrea; Mazzaferri, Fulvia; Tacconelli, Evelina; Farzaneh-Far, Afshin; Fava, Cristiano; Minuz, Pietro; Romano, Simone title: Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19–Related Disease date: 2021-12-09 journal: Am J Cardiol DOI: 10.1016/j.amjcard.2021.10.046 sha: e38b527b58960c3cdbbe833095884b30f58bd94a doc_id: 941395 cord_uid: v8sv890w Evidence of the involvement of the cardiovascular system in patients with COVID-19 is increasing. The evaluation of the subclinical cardiac involvement is crucial for risk stratification at admission, and left ventricular global longitudinal strain (LVGLS) may be useful for this purpose. A total of 87 consecutive patients admitted to the COVID Center were enrolled from December 2020 to April 2021. A complete echocardiography examination was performed within 72 hours from admission. The main outcome was the need for mechanical ventilation by way of orotracheal intubation (OTI) and mortality, and the secondary outcome was the worsening of the respiratory function during hospitalization, interpreted as a decrease of the ratio between the partial pressure of oxygen and the fraction of inspired oxygen (P/F) <100. Of 87 patients, 14 had severe disease leading to OTI or death, whereas 24 had a P/F <100. LVGLS was significantly impaired in patients with severe disease. After adjustment for risk factors, by considering LVGLS as continuous variable, the latter remained significantly associated with severe acute respiratory distress syndrome (P/F <100) (hazard ratio [HR] 1.48, 95% confidence interval [CI] 1.18 to 1.88, p = 0.001) and OTI/death (HR 1.63, 95% CI 1.13 to 2.38, p = 0.012). When using an LVGLS cutoff of −16.1%, LVGLS ≥ −16.1% was independently associated with a higher risk of severe acute respiratory distress syndrome (HR 4.0, 95% CI 1.4 to 11.1, p= 0.008) and OTI/death (HR 7.3, 95% CI 1.6 to 34.1, p = 0.024). LVGLS can detect high-risk patients at the admission, which can help to guide in starting early treatment of the admitted patients. Evidence of the involvement of the cardiovascular system in patients with COVID-19 is increasing. The evaluation of the subclinical cardiac involvement is crucial for risk stratification at admission, and left ventricular global longitudinal strain (LVGLS) may be useful for this purpose. A total of 87 consecutive patients admitted to the COVID Center were enrolled from December 2020 to April 2021. A complete echocardiography examination was performed within 72 hours from admission. The main outcome was the need for mechanical ventilation by way of orotracheal intubation (OTI) and mortality, and the secondary outcome was the worsening of the respiratory function during hospitalization, interpreted as a decrease of the ratio between the partial pressure of oxygen and the fraction of inspired oxygen (P/F) <100. Of 87 patients, 14 had severe disease leading to OTI or death, whereas 24 had a P/F <100. LVGLS was significantly impaired in patients with severe disease. After adjustment for risk factors, by considering LVGLS as continuous variable, the latter remained significantly associated with severe acute respiratory distress syndrome (P/F <100) (hazard ratio COVID-19 is a pandemic viral infection leading to SARS-CoV-2. 1 Although this respiratory syndrome is the most important cause of death, increasing evidence indicates that the cardiovascular system is affected by this disease. 2, 3 Recently, the echographic measurement of left ventricle (LV) deformation by global longitudinal strain (GLS) has been introduced as a novel marker of cardiac dysfunction. It evaluates myocardial deformation and is less influenced by loading conditions compared with ejection fraction (EF). Accumulating literature on multimodal cardiac imaging highlights the LV GLS (LVGLS) impact on the prognosis of several clinical conditions. 4−8 Moreover, LVGLS can detect initial and subclinical ventricle impairment, earlier than conventional echocardiographic parameters. 9 The evaluation of the subclinical cardiac involvement in patients with COVID-19 may be crucial and LVGLS may be useful for this purpose. Our study investigates whether LVGLS was a predictor of the decrease of respiratory function, the need for mechanical ventilation, and mortality in patients admitted to the hospital with COVID-19−related infection. A single-center, prospective study was performed at the University Hospital of Verona, Italy. We enrolled a total of 87 consecutive patients admitted to the COVID Center Unit (Internal Medicine and Infectious Disease wards) from December 2020 to April 2021. All admitted patients received bedside echocardiography within 72 hours from admission to the COVID Center Unit. The study was approved by the local Ethics Committee. Inclusion criteria were: age ≥18 years; hospitalization with a confirmed diagnosis of COVID-19; EF ≥50%. Exclusion criteria were: history of ischemic cardiomyopathy; the presence of LV segmental wall-motion abnormalities; history of heart failure; severe valvular disease; atrial fibrillation; pulmonary hypertension, chronic obstructive pulmonary disease. Upon admission, complete bloodwork, including the markers presented in this study, was performed. A database including demographic characteristics, comorbidities, laboratory exams, and outcomes was independently reviewed by a medical team using the electronic database. The respiratory impairment was assessed using the ratio between the partial a Department of Internal Medicine, Internal Medicine Section C, University Hospital of Verona, Verona, Italy; b Division of Cardiology, Department of Medicine, Duke University, Durham, North Carolina; and pressure of oxygen and the fraction of inspired oxygen (P/ F) obtained by arterial blood gas analysis. Parasternal axis, apical views, and subxiphoid view were obtained using a GE Vivid T8 ultrasound system (GE Healthcare, Arlington Heights, Illinois), (GLS normal values À18.2% to À21.2%). A digital loop, electrocardiographic gated, was acquired from 2 to 3, and 4 chamber views. All images were stored and analyzed at a later time. LVGLS was calculated by averaging the values obtained in the apical 2 to 3 and 4 chamber views (18 segments). LV endocardial borders were automatically traced at the end of the diastole, subsequently, the software tracked the endocardial layer throughout the cardiac cycle. When necessary, the operator manually adjusted the endocardial border. A segment could be excluded by the operator if it was judged not well traced ( Figure 1 ). All measurements were made blinded to other laboratory and clinical data, including patient outcomes. Two different outcomes were considered in our study: the main outcome was the need of orotracheal intubation (OTI) and mortality, whatever came first; the secondary outcome was the development of severe acute respiratory distress syndrome (ARDS) (P/F <100 mm Hg) during hospitalization. Continuous variables are presented as mean § SD or median with interquartile range based on data distribution. Categorical variables are expressed as percentages. Oneway analysis of Variance or Kruskal−Wallis were used to compare continuous variables according to the data distribution pattern. Logistic and Cox regression analyses were performed to determine if any anamnestic, clinical, or imaging variable (age, gender, hypertension, diabetes, chronic kidney disease, d-dimer, ferritin, ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/E'), and LVGLS) could be independently associated with the dependent variable (end points). The variable selection was made through sequential replacement (a stepwise method), which consists of a combination of backward and forward techniques. If the p value was <0.05 or >0.1, the covariates were respectively included and excluded from the regression model. The area under the receiver operating characteristic (ROC) curves were built to assess the performance of LVGLS (alone and together with the other dependent variables included in the model) for predicting the study end points. Furthermore, we tried to identify the optimal cut-off point of LVGLS for the prediction of the outcomes, trying to optimize sensibility and specificity in the C-statistics analysis. IBM SPSS Statistics for Windows, Version 22.0. (IBM Corp. Released 2013, Armonk, New York) was used for all data analysis. All tests were 2-sided, and p <0.05 were considered statistically significant. A total of 87 consecutive patients were enrolled in our study. Baseline anthropometric, clinical, biochemical parameters, and echocardiography data are listed in Tables 1 and 2 . Regarding specific medical therapy for COVID-19, 90% of subjects were treated with steroids, 18.8% with remdesivir, 24.4% received antibiotics, and all patients were treated with low molecular weight heparin. Patients with lower LVGLS had higher N-terminal pro brain natriuretic peptide (r = 0.58, p <0.001), no correlations were found between LVGLS and other biochemical and imaging parameters. When patients were divided into 2 subgroups The American Journal of Cardiology (www.ajconline.org) according to the end points of the study: OTI or death (n = 14; Table 1 ); development of severe ARDS (P/ F <100 mm Hg) (n = 24; Table 2 ), LVGLS was statistically significant impaired in both outcomes. ROC curves were elaborated for both end points to obtain the area under the curve, either considering LVGLS alone or on top of the other covariates after the regression models. In patients with the P/F lower than 100, LVGLS alone predicted the outcome with 78% accuracy (95% CI 0.66 to 0.88). The addition of LVGLS into the model with clinical and imaging predictors resulted in a significant increase in the C-statistic (from 0.64 to 0.85, p <0.05) (Figure 2 In this study, we report a strong correlation between the impairment of the LV longitudinal function, measured by LVGLS, with a worse prognosis in patients hospitalized for SARS-CoV-2 infection. Indeed, LVGLS measured at the moment of admission was a strong predictor of respiratory failure and mortality. Notably, in our study we excluded all patients with a history of heart or chronic pulmonary, to exclude all possible confounding factors that may be associated with poor outcomes. Cardiac injury is often seen in patients with COVID-19 disease and it is correlated to increased mortality, 10 although only a small percent of patients with COVID-19 experience myocardial involvement. 11, 12 So far, only a few studies have investigated GLS in patients with COVID-19. Xie et al 13 showed that 4 chamber longitudinal strain is associated with cardiac injury and predicts higher mortality. It also seems that biventricular longitudinal strain may improve 3 months after discharge. The ECHOVID-19 study 14 demonstrated that LVGLS is reduced in patients infected with SARS-CoV-2 compared with matched controls and correlates with COVID-19−related death. A recent meta-analysis, 15 including left and right longitudinal strain, showed that patients with poor outcomes had lower GLS, and each 1% decrease in LVGLS was associated with 1.3 £ increased risk of mortality. This result is consistent with what we observed in our study. Croft et al 16 found that LVGLS was reduced in patients with COVID-19 but it was not significantly lower in those who died compared with survivors. However, the Cox regression analysis showed a trend in the ability of LVGLS to predict the need for mechanical ventilation or death. The limited sample size of the study, given that images for measurement of LVGLS were collected only in 56% of the patients, did not probably allow to reach the statistical significance. Although troponin is a good biomarker of myocardial injury, in our study troponin was not a predictor of mortality. Thus, it remains to be determined whether SARS-CoV-2 affects the myocardium directly or the cardiac impairment is related to the systemic consequences of COVID- 19 . It has been demonstrated that systemic inflammation increases the metabolic demand, leading to cardiac stress. 17 Our findings suggest that cardiac damage is preferentially associated with LV longitudinal fibers dysfunction because of the inflammatory process, rather than ischemic stress. Probably because of their subendocardial location, the myocardial fibers are highly sensitive to disturbance by various noxae. 18 Longitudinal function plays a fundamental role in cardiac systole by reducing the longitudinal LV size as the mitral annulus is pulled toward the apex. 19 For these reasons, GLS is a sensitive marker of LV dysfunction, regardless of LV function. 20 We hypothesize that SARS-CoV-2induced systemic inflammation may induce longitudinal cardiac dysfunction from the early stages of the disease. In the present work, we also evaluated the power of LVGLS to predict the decrease of P/F to <100 mm Hg during the hospitalization, a sign of severe ARDS. In this case, LVGLS improved the prognostic power; this is clearly illustrated by ROC curves showing, with a clear trend, that LVGLS provides prognostic information incremental to common clinical risk factors. To the best of our knowledge, no other reports have studied the capability of LVGLS to predict severe respiratory failure. We hypothesize that such prediction power is related to the LVGLS capability to monitor the right ventricle dysfunction. In patients with COVID-19, multiple elements concur to right ventricle dysfunction: inflammation that causes right ventricle overload and damage, 27 ARDS, negative inotropic effects of cytokines, and direct angiotensin-converting Enzyme 2-mediated cardiac injury upon activation by SARS-CoV-2. 28 As a consequence of right ventricle dysfunction, the LV function is affected by ventricular interdependence and paradoxical septum. Limited information is available regarding the role of GLS in ARDS. For instance, Lemari e et al 29 evaluated the longitudinal function of the right ventricle in patients with ARDS, but they did not find any difference in terms of survival, however, the number of the included patients was low with a low mortality rate. Moreover, they only did a single measurement at 1 time point and it is hard to think that this can predict the long-term outcome, especially in the complex setting of critical care. We believe that left and right GLS can be useful and powerful markers in patients affected by ARDS, even for the prediction of respiratory failure as demonstrated in this report. Further studies are, however, needed to assess the exact role of GLS in patients with ARDS. In conclusion, our findings show that LVGLS can represent a novel and early marker of cardiac dysfunction, even in low-risk patients without cardiac diseases, which can predict mortality and respiratory failure in patients with COVID-19. For this reason, because of the fast and noninvasive methodology, and the low cost of echocardiography and LVGLS, we propose its assessment in patients admitted for COVID-19-related disease and in patients with ARDS. LVGLS is crucial to unmask subclinical cardiac dysfunction, especially in patients with preserved EF, allowing to identify, at the moment of the admission, high-risk patients who are not otherwise identified. Moreover, there are not many therapeutic options for patients with COVID-19 (i.e., monoclonal antibody, new coming antiviral medications) and LVGLS can be crucial for risk stratification and therefore for decision-making on early treatment at the moment of admission This study, however, presents some limitations. First, this is a single-center study and therefore the sample size, although consistent with other similar studies, is limited; second, systemic inflammation was only partially studied; third, right ventricle GLS and atrial strain were not evaluated. Larger studies are needed to confirm and expand the present results. The authors have no conflicts of interest to declare. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Left ventricular global longitudinal strain predicts heart failure readmission in acute decompensated heart failure Farzaneh-Far A. Association of featuretracking cardiac magnetic resonance imaging left ventricular global longitudinal strain With all-cause mortality in patients With reduced left ventricular ejection fraction Farzaneh-Far A. Featuretracking global longitudinal strain predicts death in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy incremental to ejection fraction and late gadolinium enhancement Prognostic implications of mitral annular plane systolic excursion in patients with hypertension and a clinical indication for cardiac magnetic resonance imaging: a multicenter study Farzaneh-Far A. Feature-tracking global longitudinal strain predicts mortality in patients with preserved ejection fraction: a multicenter study Ten years of 2D longitudinal strain for early myocardial dysfunction detection: a clinical overview Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan Biventricular longitudinal strain predict mortality in COVID-19 patients Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients Influenza vaccination as secondary prevention for cardiovascular disease Left and right ventricular long-axis function and prognosis Long axis function in disease Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction COVID-19 and the cardiovascular system 2D speckle tracking imaging to assess sepsis induced early systolic myocardial dysfunction and its underlying mechanisms Advantages of strain echocardiography in assessment of myocardial function in severe sepsis: an experimental study Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis The relation between left ventricular global longitudinal strain and troponin levels in patients hospitalized with COVID-19 pneumonia Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study Coronaviruses and the cardiovascular system: acute and long-term implications In the eye of the storm: the right ventricle in COVID-19 Feasibility, reproducibility and diagnostic usefulness of right ventricular strain by 2-dimensional speckle-tracking echocardiography in ARDS patients: the ARD strain study The authors wish to thank all patients and their families for having accepted to be involved in this study.